Incidence of acute serious bacterial infections one year [clinicaltrials_resource:427eaedec4b3a42e4a2f9715310c0309]
Acute serious bacterial infections are defined in The FDA(CBER) Guidance for industry for studies of IGIV to support marketing of IGIV as replacement therapy for primary humoral immunodeficiency (June, 2008).
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Incidence of acute serious bacterial infections one year [clinicaltrials_resource:427eaedec4b3a42e4a2f9715310c0309]
Acute serious bacterial infections are defined in The FDA(CBER) Guidance for industry for studies of IGIV to support marketing of IGIV as replacement therapy for primary humoral immunodeficiency (June, 2008).
Bio2RDF identifier
427eaedec4b3a42e4a2f9715310c0309
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:427eaedec4b3a42e4a2f9715310c0309
measure [clinicaltrials_vocabulary:measure]
Incidence of acute serious bacterial infections
time frame [clinicaltrials_vocabulary:time-frame]
description
Acute serious bacterial infect ...... immunodeficiency (June, 2008).
identifier
clinicaltrials_resource:427eaedec4b3a42e4a2f9715310c0309
title
Incidence of acute serious bacterial infections one year
@en
type
label
Incidence of acute serious bac ...... eaedec4b3a42e4a2f9715310c0309]
@en